How our research is different

People, not test tubes

Health solutions for chronic disease and injury prevention are often surprisingly simple and quick to implement. We focus on understanding what puts people at risk of death and disability from the most common types of injury, chronic and critical conditions, such as heart disease, diabetes and stroke.

Faster results, better health outcomes

This offers great opportunities to improve and even save lives, cost-effectively, in a short time. In biomedical research, it can take decades before research findings are translated into medical practice. The Institute’s goal is to generate outputs that can effect crucial change within a five year timeframe.

Seeing research through to practice

Once the results of our research are published we actively engage in the translation of our work into policy guidelines and practice, influencing policy-makers to bring the best available evidence into their decision making. We develop health innovations, conceptualising and testing novel technologies for use by clinicians, assessing their value and delivering them into the primary health care setting.

Unique funding model

As part of our unique funding model, we house a strategic enterprise, George Clinical, which designs and manages large-scale clinical trials both for the Institute itself and for pharmaceutical and medical research organisations worldwide.